glp 1 receptor agonists beyond their pancreatic effects PDF) GLP-1 Agonists: GLP1 Receptor Agonists—Effects beyond Obesity
Description
Now, a new study provides the first randomized, placebo-controlled clinical evidence that semaglutide, a widely used GLP-1 drug, slows down the accumulation of biological aging markers in the DNA of adults with HIV
A brief description of this section is listed in Table 7
2023;136(12):e2334
Diabetologia (2018) 61(10):210817
2012;18:BR 286BR 291
Some studies have reported GLP-1R expression in both transformed hepatocyte cell lines (HuH7 and Hep-G2) and in primary human hepatocytes
